This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: Neurosearch A/s. Active years: 2004-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Solrod Strand, DK (2004)
- Ballerup, DK (2008)
Company Filing History:
Years Active: 2004-2008
Title: Tino Dyhring Jorgensen: Innovator in Pharmacological Compounds
Introduction
Tino Dyhring Jorgensen is a notable inventor based in Ballerup, Denmark. He has made significant contributions to the field of pharmacology, particularly through his innovative compounds that target various neurological and physiological disorders. With a total of three patents to his name, Jorgensen's work is recognized for its potential therapeutic applications.
Latest Patents
Jorgensen's latest patents include novel 2,5-diazabicyclo[2.2.1]heptane derivatives. These compounds are identified as potent modulators of monoamine receptors and transporters. Their pharmacological profile suggests they may be beneficial in treating a range of diseases and disorders, including those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), and various conditions associated with smooth muscle contraction, endocrine issues, neuro-degeneration, inflammation, pain, and withdrawal symptoms from chemical substance abuse. Another significant patent involves compounds that act as cholinergic ligands at nicotinic acetylcholine receptors, further emphasizing their potential in addressing diverse health challenges.
Career Highlights
Jorgensen is currently associated with Neurosearch A/S, a company dedicated to advancing research in neuropharmacology. His work at Neurosearch has allowed him to explore innovative solutions for complex medical conditions, contributing to the company's reputation in the field.
Collaborations
Throughout his career, Jorgensen has collaborated with esteemed colleagues, including Dan Peters and Gunnar M. Olsen. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmacological compounds.
Conclusion
Tino Dyhring Jorgensen stands out as an influential inventor in the realm of pharmacological innovations. His patents reflect a commitment to addressing critical health issues through scientific advancement. His contributions continue to pave the way for future developments in the treatment of various disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile